• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Crude Oil Up 1%; M&T Bank Posts Upbeat Q2 Results

    7/19/23 12:18:04 PM ET
    $AMRN
    $AQMS
    $CVNA
    $HROW
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Metal Fabrications
    Industrials
    Get the next $AMRN alert in real time by email

    U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 0.5% on Wednesday.

    The Dow traded up 0.53% to 35,137.16 while the NASDAQ rose 0.48% to 14,422.74. The S&P 500, also rose, gaining, 0.43% to 4,574.42.

    Check This Out: Tesla Likely To Report Higher Q2 Earnings; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

     

    Leading and Lagging Sectors

    • Utilities shares climbed by 1.1% on Wednesday.
    • In trading on Wednesday, materials shares fell by 0.5%.

     

    Top Headline

    M&T Bank Corporation (NYSE:MTB) reported better-than-expected second-quarter results.

    M&T Bank reported quarterly revenue of $2.60 billion, beating the consensus of $2.39 billion. EPS was $5.12, beating the consensus of $4.11.

     

    Equities Trading UP

    • Harrow Health, Inc. (NASDAQ:HROW) shares shot up 17% to $21.34 after the company acquired US & Canadian rights to certain eye disease products and announced a $60 million equity offering.
    • Shares of Panbela Therapeutics, Inc. (NASDAQ:PBLA) got a boost, shooting 33% to $2.75 after the company divested certain assets in its eflornithine pediatric neuroblastoma program to US WorldMeds for $9.5 million.
    • Carvana Co. (NYSE:CVNA) shares were also up, gaining 28% to $51.04 after the company reported better-than-expected second-quarter sales and guided positive adj. EBITDA for the third quarter. Carvana entered into distribution agreement with Citigroup, Moelis relating to offering of up to $1 billion of class A common stock.

     

    Equities Trading DOWN

    • Sono Group N.V. (NASDAQ:SEV) shares dropped 34% to $0.2213 after the company received a notice of delisting from the Nasdaq.
    • Shares of Amarin Corporation plc (NASDAQ:AMRN) were down 23% to $1.10 after the company initiated an organizational restructuring program and issued lower interim second-quarter revenues.
    • Aqua Metals, Inc. (NASDAQ:AQMS) was down, falling 19% to $1.3699. Aqua Metals prices $17.4 million public offering of 15.82 million shares of common stock at a price of $1.10 per share.

    Also Check This Out: Top 5 Risk Off Stocks That May Crash This Month

     

    Commodities

    In commodity news, oil traded up 1.2% to $76.67 while gold traded down 0.2% at $1,977.30.

    Silver traded up 0.4% to $25.36 on Wednesday while copper fell 0.8% to $3.7995.

     

    Euro zone

    European shares were higher today. The eurozone’s STOXX 600 rose 0.47%, London’s FTSE 100 gained 2.2% while Spain’s IBEX 35 Index gained 0.06% The German DAX gained 0.14% French CAC 40 rose 0.34% and Italy’s FTSE MIB Index rose 0.19%.

    The consumer price inflation rate in the Eurozone was confirmed at 5.5% in June, notching the lowest level since Jan. 2022. Construction output in the Eurozone increased 0.1% from the prior year in May, compared to the revised 0.4% growth in the earlier month. Passenger car registrations in the European Union jumped 17.8% year-over-year to 1 million units in June.

    Consumer price inflation in the UK fell to 7.9% in June, recording the lowest level since March 2022, while producer inflation slowed to 0.1% year-over-year in June compared to a revised 2.7% in the prior month.

     

    Asia Pacific Markets

    Asian markets closed mostly higher on Wednesday, with Japan’s Nikkei 225 gaining 1.24%, China’s Shanghai Composite Index falling 0.33% and Hong Kong’s Hang Seng Index gaining 0.03%. India’s S&P BSE Sensex, meanwhile, rose 0.45%.

    The Reuters Tankan sentiment index for manufacturers in Japan declined to a reading of +3 in July versus +8 in June.

     

    Economics

    • Mortgage applications in the U.S. rose 1.1% in the week ended July 14, 2023, versus a 0.9% growth in the prior week.
    • Housing starts in the U.S. fell by 8% month-over-month to an annualized rate of 1.434 million in June, compared to market estimates of 1.48 million.
    • Building permits in the U.S. fell by 3.7% to an annual rate of 1.44 million in June.
    • U.S. crude-oil inventories fell 700,000 barrels last week, the EIA said.

    Now Read This: Coinbase Global, Moderna And 2 Other Stocks Insiders Are Selling

     

    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 107,400,110 cases with around 1,168,940 deaths. India confirmed a total of at least 44,994,920 cases and 531,910 deaths, while France reported over 40,138,560 COVID-19 cases with 167,640 deaths. In total, there were at least 691,724,010 cases of COVID-19 worldwide with more than 6,900,710 deaths.

    Get the next $AMRN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMRN
    $AQMS
    $CVNA
    $HROW

    CompanyDatePrice TargetRatingAnalyst
    M&T Bank Corporation
    $MTB
    1/7/2026Outperform → Peer Perform
    Wolfe Research
    M&T Bank Corporation
    $MTB
    1/7/2026$225.00Buy → Neutral
    BofA Securities
    Carvana Co.
    $CVNA
    12/15/2025$500.00Buy
    Argus
    M&T Bank Corporation
    $MTB
    12/12/2025$217.00Buy → Hold
    Truist
    Carvana Co.
    $CVNA
    12/1/2025$450.00Buy
    UBS
    Carvana Co.
    $CVNA
    11/24/2025$400.00Neutral → Outperform
    Wedbush
    Carvana Co.
    $CVNA
    11/21/2025$395.00Buy
    Deutsche Bank
    Carvana Co.
    $CVNA
    11/12/2025$390.00Overweight
    Barclays
    More analyst ratings

    $AMRN
    $AQMS
    $CVNA
    $HROW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    M&T Bank downgraded by Wolfe Research

    Wolfe Research downgraded M&T Bank from Outperform to Peer Perform

    1/7/26 8:57:45 AM ET
    $MTB
    Major Banks
    Finance

    M&T Bank downgraded by BofA Securities with a new price target

    BofA Securities downgraded M&T Bank from Buy to Neutral and set a new price target of $225.00

    1/7/26 8:57:24 AM ET
    $MTB
    Major Banks
    Finance

    Argus initiated coverage on Carvana with a new price target

    Argus initiated coverage of Carvana with a rating of Buy and set a new price target of $500.00

    12/15/25 8:51:06 AM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    $AMRN
    $AQMS
    $CVNA
    $HROW
    SEC Filings

    View All

    Aptera Motors Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Aptera Motors Corp (0001786471) (Filer)

    3/3/26 8:05:44 AM ET
    $SEV
    Auto Manufacturing
    Industrials

    SEC Form 10-K filed by Amarin Corporation plc

    10-K - AMARIN CORP PLC\UK (0000897448) (Filer)

    3/2/26 5:31:01 PM ET
    $AMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by Harrow Inc.

    10-K - HARROW, INC. (0001360214) (Filer)

    3/2/26 4:31:33 PM ET
    $HROW
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMRN
    $AQMS
    $CVNA
    $HROW
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Harrow to Present at Leerink Partner's 2026 Global Healthcare Conference

    NASHVILLE, Tenn., March 04, 2026 (GLOBE NEWSWIRE) -- Harrow (NASDAQ:HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that management will present at Leerink Partner's 2026 Global Healthcare Conference on Tuesday, March 10, 2026, at 8:40 AM ET, in Miami, Florida. The presentation will be webcast live and can be found on the Company's website. A replay will be on the website for approximately 90 days following the event. About HarrowHarrow, Inc. (NASDAQ:HROW) is a leading provider of ophthalmic disease management solutions in North America, offering a comprehensive portfolio of products that address conditions affecting both the front a

    3/4/26 7:00:00 AM ET
    $HROW
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Aptera Motors Completes First Vehicle off Validation Assembly Line

    CARLSBAD, Calif., March 03, 2026 (GLOBE NEWSWIRE) -- Aptera Motors Corp. (NASDAQ:SEV), a solar mobility company advancing ultra-efficient transportation, has completed the first vehicle off its validation assembly line, marking a major operational milestone as the company progresses toward regulatory certification and initial customer deliveries. The company's low-volume validation assembly line represents Aptera's transition from hand-built validation vehicles to a structured assembly line process. The line consists of 14 dedicated stations, where vehicles are assembled by a team of vehicle line technicians, enabling repeatable builds, process verification, and optimization. Vehicles

    3/3/26 8:00:00 AM ET
    $SEV
    Auto Manufacturing
    Industrials

    Harrow to Initiate Phase 3 Clinical Trial Seeking to Expand TRIESENCE® Label to Include Ocular Inflammation and Pain Following Cataract Surgery Indication

    NASHVILLE, Tenn., March 03, 2026 (GLOBE NEWSWIRE) -- Harrow (NASDAQ:HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that the U.S. Food and Drug Administration (FDA) has cleared an Investigational New Drug (IND) application to support a planned Phase 3 clinical trial evaluating TRIESENCE (preservative-free triamcinolone acetonide injectable suspension) 40 mg/mL for the treatment of ocular inflammation and pain following cataract surgery. The planned Phase 3 study is a randomized, placebo-controlled, double-masked, multicenter clinical trial designed to evaluate the safety and efficacy of TRIESENCE in patients undergoing cataract surger

    3/3/26 7:00:00 AM ET
    $HROW
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMRN
    $AQMS
    $CVNA
    $HROW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Opaleye Management Inc. sold $7,846,426 worth of shares (198,572 units at $39.51) (SEC Form 4)

    4 - HARROW, INC. (0001360214) (Issuer)

    3/5/26 4:05:14 PM ET
    $HROW
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Officer Breaux Paul W. covered exercise/tax liability with 774 shares, decreasing direct ownership by 1% to 67,288 units (SEC Form 4)

    4 - CARVANA CO. (0001690820) (Issuer)

    3/3/26 5:41:12 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    President, Special Projects Taira Thomas covered exercise/tax liability with 675 shares, decreasing direct ownership by 1% to 65,950 units (SEC Form 4)

    4 - CARVANA CO. (0001690820) (Issuer)

    3/3/26 5:40:46 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    $AMRN
    $AQMS
    $CVNA
    $HROW
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Berg Aaron bought $102,400 worth of Ordinary Shares (160,000 units at $0.64), increasing direct ownership by 25% to 805,380 units (SEC Form 4)

    4 - AMARIN CORP PLC\UK (0000897448) (Issuer)

    8/5/24 5:30:03 PM ET
    $AMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Yi Sung bought $29,250 worth of shares (75,000 units at $0.39) (SEC Form 4)

    4 - Aqua Metals, Inc. (0001621832) (Issuer)

    5/16/24 9:33:56 PM ET
    $AQMS
    Metal Fabrications
    Industrials

    Smith Edward J bought $9,750 worth of shares (25,000 units at $0.39), increasing direct ownership by 8% to 334,050 units (SEC Form 4)

    4 - Aqua Metals, Inc. (0001621832) (Issuer)

    5/16/24 8:21:08 PM ET
    $AQMS
    Metal Fabrications
    Industrials

    $AMRN
    $AQMS
    $CVNA
    $HROW
    Leadership Updates

    Live Leadership Updates

    View All

    M&T Bank Appoints Jeff Carpenter Regional President for Massachusetts

    Industry veteran brings 20+ years of expertise to drive growth, reinforce commitment to customer service and lead community engagement BOSTON, Feb. 2, 2026 /PRNewswire/ -- M&T Bank (NYSE: MTB) today announced the appointment of Jeff Carpenter as its new Regional President of Massachusetts. With more than two decades of corporate and specialty banking experience, Carpenter brings deep regional knowledge, financial expertise and a strong record of leadership to this role, reinforcing M&T's commitment to delivering exceptional service to its customers. Carpenter has served as Executive Vice President, Head of Specialty and Corporate Banking since 2023. In his expanded role as Regional President

    2/2/26 7:05:00 AM ET
    $MTB
    Major Banks
    Finance

    Aptera Motors Appoints Automotive Industry Veteran Tony Kirton as Chairman of the Board of Directors

    CARLSBAD, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Aptera Motors Corp. (NASDAQ:SEV), a solar mobility company advancing ultra-efficient transportation, today announced that Tony Kirton has been appointed Chairman of the Board of Directors. Kirton brings more than four decades of global automotive leadership experience, having held senior executive and board roles across leading automotive brands including Volkswagen, Audi, and BMW. His appointment follows his service as an independent board director and supports Aptera's focus on disciplined governance and long-term value creation as the company prepares for production. "Over my career, I've seen many technologies promise transformation

    1/8/26 4:49:26 PM ET
    $SEV
    Auto Manufacturing
    Industrials

    CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 22, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.  Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Dec 22, 2025  S&P 500 Addition CRH CRH Mat

    12/5/25 5:49:00 PM ET
    $ASIX
    $BAH
    $BWA
    Major Chemicals
    Industrials
    Professional Services
    Consumer Discretionary

    $AMRN
    $AQMS
    $CVNA
    $HROW
    Financials

    Live finance-specific insights

    View All

    Harrow Announces Q4 and Full-Year 2025 Financial Results and 2026 Financial Guidance

    Fourth Quarter, Full-Year 2025 and Selected Highlights:  Record quarterly revenue of $89.1 million, a 33% increase over $66.8 million recorded in the prior-year periodFull-Year revenue of $272.3 million, a 36% increase over $199.6 million recorded in 2024GAAP net income of $6.6 million in Q4 2025, and net loss $5.1 million for 2025Adjusted EBITDA of $24.2 million in Q4 2025, and $61.9 million for 2025Generated $43.9 million of operating cash flow in 2025, versus $(22.2) million used in operations in 2024Cash and cash equivalents of $72.9 million as of December 31, 2025Full-year 2026 revenue guidance of $350 million to $365 million, including $133 million to $153 million in the first half of

    3/2/26 4:05:00 PM ET
    $HROW
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amarin Reports Fourth Quarter and Full Year 2025 Financial Results

    Strategic Initiatives and Refined Business Model Produced Financial and Operating Efficiencies Established Long-Term License and Supply Agreement to Commercialize VAZKEPA® Across Europe and Sustained U.S. Market Leadership for VASCEPA® Franchise Total of 45 Publications (Abstracts, Posters, Manuscripts) Furthering the Expansion of the VASCEPA® /VAZKEPA® (icosapent ethyl) Body of Knowledge Supported in 2025 DUBLIN, Ireland and BRIDGEWATER, N.J., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a company committed to advancing the science of cardiovascular disease worldwide, today announced financial results for the fourth quarter and full year ended December 31, 20

    2/25/26 7:00:00 AM ET
    $AMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Carvana Announces Record Fourth Quarter and Full Year 2025 Results

    Record Full Year Retail Units Sold of 596,641, up 43% YoY Record Full Year Revenue of $20.3 billion, up 49% YoY Record Full Year Net Income of $1.9 billion1, up more than $1 billion YoY Record Full Year Adjusted EBITDA of $2.2 billion, up more than $850 million YoY Expects Significant Growth in Retail Units Sold and Adjusted EBITDA2 in FY 2026 and Sequential Increase in Retail Units Sold and Adjusted EBITDA2 in Q1 Carvana (NYSE:CVNA), a leading e-commerce platform for buying and selling cars, today announced financial results for the full year and quarter ended December 31, 2025. Carvana's complete fourth quarter and fiscal year 2025 financial results and management commentary are

    2/18/26 4:05:00 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    $AMRN
    $AQMS
    $CVNA
    $HROW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Harrow Inc.

    SC 13G/A - HARROW, INC. (0001360214) (Subject)

    12/5/24 7:08:52 PM ET
    $HROW
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Carvana Co.

    SC 13G/A - CARVANA CO. (0001690820) (Subject)

    11/14/24 5:58:14 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary